July 2023
Blinken: We Are Not in a Position to Discuss a Nuclear Agreement with Iran
U.S. Secretary of State Antony Blinken stated that the U.S. is not currently discussing a nuclear agreement with Iran, emphasizing the need for Iran to…
Continuing Ambiguity in Reviving the JCPOA; Iran's Uranium Reserves Have Increased
Iran's uranium reserves have increased significantly, raising concerns amid stalled negotiations over the JCPOA. U.S. officials express skepticism about reviving the nuclear deal, while Iranian…
Ali Akbar Salehi Calls for Comprehensive Negotiations Between the Islamic Republic and the United States
Ali Akbar Salehi, a prominent Iranian diplomat, has called for comprehensive negotiations between Iran and the U.S. to address various issues beyond previous discussions. He…
Alireza Beigi's Account of the Second Session of the SUV Court: The Names of 153 Other Recipients of Vehicles Remain Unknown
Alireza Beigi, an Iranian MP, reported on the second court session regarding the scandal of SUV allocations to legislators, revealing that 153 additional recipients remain…
Committee to Protect Journalists Calls for 'Unconditional' Release of Nazila Maroufian, Investigative Journalist
Nazila Maroufian, an investigative journalist, was arrested by security forces, prompting the Committee to Protect Journalists to demand her unconditional release. Maroufian has faced previous…
US State Department Calls for Immediate Release of 'All Political Prisoners' in Iran
The US State Department condemned the prison sentence of Iranian rapper Tomaj Salehi, calling it unjust and a violation of human rights. They demand his…
Transformation in Alzheimer's Treatment; U.S. Issues Approval for 'Lecanemab'
The U.S. FDA has approved Lecanemab, a new Alzheimer's drug that slows disease progression, costing about $26,050 annually. Developed by Eisai and Biogen, this drug…